Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Receivables (2016 - 2026)

Kewaunee Scientific (KEQU) has 15 years of Receivables data on record, last reported at $73.1 million in Q4 2025.

  • For Q4 2025, Receivables rose 73.76% year-over-year to $73.1 million; the TTM value through Oct 2025 reached $73.1 million, up 73.76%, while the annual FY2025 figure was $75.1 million, 31.94% up from the prior year.
  • Receivables reached $73.1 million in Q4 2025 per KEQU's latest filing, up from $69.3 million in the prior quarter.
  • Across five years, Receivables topped out at $75.1 million in Q2 2025 and bottomed at $36.4 million in Q1 2022.
  • Average Receivables over 5 years is $49.7 million, with a median of $43.7 million recorded in 2021.
  • Peak YoY movement for Receivables: decreased 20.49% in 2023, then surged 73.76% in 2025.
  • A 5-year view of Receivables shows it stood at $38.6 million in 2021, then soared by 40.32% to $54.2 million in 2022, then fell by 20.49% to $43.1 million in 2023, then fell by 2.43% to $42.1 million in 2024, then skyrocketed by 73.76% to $73.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables were $73.1 million in Q4 2025, $69.3 million in Q3 2025, and $75.1 million in Q2 2025.